Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. [electronic resource]
Producer: 20110516Description: 187-92 p. digitalISSN:- 1095-6859
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carboplatin -- administration & dosage
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- Dasatinib
- Drug Synergism
- Female
- Gene Expression -- drug effects
- Humans
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Proto-Oncogene Proteins pp60(c-src) -- biosynthesis
- Pyrimidines -- administration & dosage
- Thiazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.